Airflow Obstruction in Adults with Williams Syndrome and Mice with Elastin Insufficiency.
Williams Beuren syndrome
air trapping
obstructive pulmonary disease
pulmonary function tests
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
10 Jun 2022
10 Jun 2022
Historique:
received:
18
04
2022
revised:
05
06
2022
accepted:
07
06
2022
entrez:
24
6
2022
pubmed:
25
6
2022
medline:
25
6
2022
Statut:
epublish
Résumé
Williams−Beuren syndrome (WS) results from the deletion of 25−27 coding genes, including elastin (ELN), on human chromosome 7q11.23. Elastin provides recoil to tissues; emphysema and chronic obstructive pulmonary disease have been linked to its destruction. Consequently, we hypothesized that elastin insufficiency would predispose to obstructive features. Twenty-two adults with WS (aged 18−55) and controls underwent pulmonary function testing, 6 min walk, and chest computed tomography (CT). Lung and airspace dimensions were assessed in Eln+/− and control mice via microCT and histology. The forced expiratory volume in 1 s (FEV1) and the ratio of FEV1 to forced vital capacity (FVC) were lower in adults with WS (p < 0.0001 and p < 0.05, respectively). The FEV1/FVC ratio was more frequently below the lower limit of normal in cases (p < 0.01). The ratio of residual volume to total lung capacity (RV/TLC, percent predicted) was higher in cases (p < 0.01), suggesting air trapping. People with WS showed reduced exercise capacity (p < 0.0001). In Eln+/− mice, ex vivo lung volumes were increased (p < 0.0001), with larger airspaces (p < 0.001). Together these data show that elastin insufficiency impacts lung physiology in the form of increased air trapping and obstruction, suggesting a role for lung function monitoring in adults with WS.
Identifiants
pubmed: 35741248
pii: diagnostics12061438
doi: 10.3390/diagnostics12061438
pmc: PMC9221558
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : NIH HHS
ID : ZIA HL006212
Pays : United States
Références
J Invest Dermatol. 2005 Jun;124(6):1193-9
pubmed: 15955094
Am J Respir Cell Mol Biol. 2005 Oct;33(4):355-62
pubmed: 16081882
J Child Neurol. 2002 Apr;17(4):269-71
pubmed: 12088082
Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7
pubmed: 12091180
J Biol Chem. 2011 Dec 30;286(52):44926-36
pubmed: 22049077
Eur Respir J. 2005 Aug;26(2):319-38
pubmed: 16055882
Nat Rev Dis Primers. 2021 Jun 17;7(1):42
pubmed: 34140529
BMC Pulm Med. 2019 Nov 9;19(1):206
pubmed: 31706309
Case Rep Pediatr. 2017;2017:3480980
pubmed: 28626595
Nature. 1998 May 21;393(6682):276-80
pubmed: 9607766
Am J Med Genet A. 2021 Feb;185(2):390-396
pubmed: 33174385
Am J Med Genet A. 2014 Sep;164A(9):2217-25
pubmed: 24920525
Am J Med Genet A. 2017 Aug;173(8):2235-2239
pubmed: 28574231
Am J Respir Cell Mol Biol. 2009 Jun;40(6):751-5
pubmed: 19029017
Pediatr Cardiol. 2005 Nov-Dec;26(6):827-31
pubmed: 15990952
Circ Cardiovasc Imaging. 2018 Dec;11(12):e007653
pubmed: 30525986
Matrix Biol. 2019 Nov;84:31-40
pubmed: 31669522
J Clin Invest. 1998 Nov 15;102(10):1783-7
pubmed: 9819363
Matrix Biol. 2018 Nov;73:6-20
pubmed: 29331337
Age (Dordr). 2009 Dec;31(4):305-25
pubmed: 19588272
J Clin Invest. 1991 May;87(5):1828-34
pubmed: 2022748
Matrix Biol. 2018 Oct;71-72:144-160
pubmed: 29501665
Am J Med Genet A. 2010 Mar;152A(3):653-6
pubmed: 20186780
Circulation. 2013 May 28;127(21):2125-34
pubmed: 23716381
Circulation. 1962 Dec;26:1235-40
pubmed: 13967885
J Vis Exp. 2020 Jun 20;(160):
pubmed: 32628170
Am J Physiol Lung Cell Mol Physiol. 2007 Mar;292(3):L778-87
pubmed: 17142349
Circ Cardiovasc Imaging. 2008 Nov;1(3):235-43
pubmed: 19808548
Am J Med Genet A. 2012 Aug;158A(8):2053-4
pubmed: 22740173
Am J Respir Crit Care Med. 2019 Oct 15;200(8):e70-e88
pubmed: 31613151